You are here

Tsutomu Takeuchi, MD, PhD

Tsutomu Takeuchi, MD, PhD, received his doctorate of medicine and doctorate of philosophy from Keio University in Japan. He underwent postdoctoral training at the Dana-Farber Cancer Institute as a research fellow. He then worked at Saitama Medical University and became a professor of medicine and then Vice Dean of the university. In 2009, he returned to Keio University as a professor of the Division of Rheumatology and has been the General Director of Keio University Hospital since 2013. He continues his research on clinical immunology and molecular biology while providing medical care to many patients in the outpatient department.

Financial Disclosures:

Consultant/Advisor: AbbVie Inc.; Asahi Kasei Corporation; Astellas Pharma Inc.; AstraZeneca; Bristol-Myers Squibb Company; Daiichi Sankyo Company, Limited; Eli Lilly and Company; Janssen Global Services, LLC; Merck KGaA; Mitsubishi Tanabe Pharma Corporation; Pfizer Inc.; Nippon Kayaku Co.,Ltd.; Takeda Pharmaceutical Company Limited;

Grant/Research Support: AbbVie Inc.; Asahi Kasei Corporation; Astellas Pharma Inc.; AYUMI Pharmaceutical Corporation; Bristol-Myers Squibb Company; Chugai Pharmaceutical Co., Ltd; Daiichi Sankyo Company, Limited; Eisai Co., Ltd.; Taisho Pharmaceuticals Co., Ltd.; Takeda Pharmaceutical Company Limited;

Speakers’ Bureau: AbbVie Inc.; Astellas Pharma Inc.; Bristol-Myers Squibb Company; Chugai Pharmaceutical Co., Ltd; Daiichi Sankyo Company, Limited; Eisai Co., Ltd.; Janssen Global Services, LLC; Mitsubishi Tanabe Pharma Corporation; Nippon Kayaku Co.,Ltd.; Pfizer Inc.;